Diligence memo · auto-generated · as of July 2, 2026
RxCap, Inc.
RxCap, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
RxCap, Inc. operates in Other Technology, based in LYNNFIELD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
RxCap, Inc. has raised $20M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $20M on 2024-04-25.
Most recent recorded round closed around 2024-04-25.
Valuation (modeled)modeled
Provath models RxCap, Inc. at approximately $157M (range $48M–$290M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.73× the median modeled value of Series B Other Technology companies in 2022–2024 (514 peers) — value vs value, same stage and era. Within the normal band (73% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2.2 yr ago; this sector typically re-raises about every 13 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 83% of Other Technology peers (21292 compared).
Modeled value ranks above 80% of those peers.
Closest niche peers: Contabilizei Co, Skan, Inc., Design Barn Inc., SKAEL, Inc., Maze.Design, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.